KR101489728B1 - 남조류의 정제된 성분 및 이용 방법 - Google Patents

남조류의 정제된 성분 및 이용 방법 Download PDF

Info

Publication number
KR101489728B1
KR101489728B1 KR20087001941A KR20087001941A KR101489728B1 KR 101489728 B1 KR101489728 B1 KR 101489728B1 KR 20087001941 A KR20087001941 A KR 20087001941A KR 20087001941 A KR20087001941 A KR 20087001941A KR 101489728 B1 KR101489728 B1 KR 101489728B1
Authority
KR
South Korea
Prior art keywords
extract
selectin
delete delete
cells
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR20087001941A
Other languages
English (en)
Korean (ko)
Other versions
KR20080030047A (ko
Inventor
기테 에스. 젠센
크리스챤 드라페아우
Original Assignee
데저트 레이크 테크놀로지스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데저트 레이크 테크놀로지스 filed Critical 데저트 레이크 테크놀로지스
Publication of KR20080030047A publication Critical patent/KR20080030047A/ko
Application granted granted Critical
Publication of KR101489728B1 publication Critical patent/KR101489728B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
KR20087001941A 2005-06-24 2006-06-23 남조류의 정제된 성분 및 이용 방법 Expired - Fee Related KR101489728B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US69380805P 2005-06-24 2005-06-24
US60/693,808 2005-06-24
US70088205P 2005-07-19 2005-07-19
US60/700,882 2005-07-19
PCT/US2006/024769 WO2007002570A1 (en) 2005-06-24 2006-06-23 Purified component of blue-green algae and method of use

Publications (2)

Publication Number Publication Date
KR20080030047A KR20080030047A (ko) 2008-04-03
KR101489728B1 true KR101489728B1 (ko) 2015-02-04

Family

ID=37188001

Family Applications (1)

Application Number Title Priority Date Filing Date
KR20087001941A Expired - Fee Related KR101489728B1 (ko) 2005-06-24 2006-06-23 남조류의 정제된 성분 및 이용 방법

Country Status (12)

Country Link
US (3) US7651690B2 (cg-RX-API-DMAC10.html)
EP (1) EP1895973B1 (cg-RX-API-DMAC10.html)
JP (1) JP5006877B2 (cg-RX-API-DMAC10.html)
KR (1) KR101489728B1 (cg-RX-API-DMAC10.html)
AU (1) AU2006261852B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0612672B8 (cg-RX-API-DMAC10.html)
CA (1) CA2612694C (cg-RX-API-DMAC10.html)
ES (1) ES2546332T3 (cg-RX-API-DMAC10.html)
IL (1) IL188192A (cg-RX-API-DMAC10.html)
NZ (1) NZ565346A (cg-RX-API-DMAC10.html)
RU (1) RU2417093C2 (cg-RX-API-DMAC10.html)
WO (1) WO2007002570A1 (cg-RX-API-DMAC10.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6814961B1 (en) * 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
EP2026759B1 (en) * 2006-05-05 2015-07-08 Blaa Lonid Hf. Pharmaceutical and cosmetic use of extracts from algae obtainable from saline hot water sources
DK2046354T3 (da) * 2006-06-27 2011-10-31 Nutratec S R L Aphanizomenon Flos Aquae-fremstilling, ekstrakter og oprensede bestanddele deraf til behandling af neurologiske, neurodegenerative og humørforstyrrelser
AU2007264043B2 (en) * 2006-06-27 2012-03-15 Nutratec S.R.L. Extracts of Aphanizomenon Flos Aquae and nutritional, cosmetic and pharmaceutical compositions containing the same
US20080124318A1 (en) * 2006-11-28 2008-05-29 Jerold Lisson Algae supplement and treatment method
KR20100062140A (ko) * 2008-12-01 2010-06-10 부경대학교 산학협력단 푸코이단을 함유하는 골 형성 촉진 및 활성용 약학 조성물
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
US9370537B2 (en) * 2009-04-03 2016-06-21 Cerule, Llc Compositions and methods for reducing inflammation
IT1394412B1 (it) * 2009-06-05 2012-06-15 Eni Spa Procedimento per l'essiccazione di biomassa algale
US20140199380A1 (en) * 2010-05-11 2014-07-17 Benzion Geshuri Pharmaceutical composition comprising an algae adapted to increase the efficacy of an enzymatic inhibitor
BR112012033548A2 (pt) * 2010-06-28 2017-06-20 Stemtech Int Inc métodos e composições para melhorar a mobilização de células-tronco
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
US8685845B2 (en) 2010-08-20 2014-04-01 International Business Machines Corporation Epitaxial growth of silicon doped with carbon and phosphorus using hydrogen carrier gas
TWI614340B (zh) 2011-09-28 2018-02-11 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
WO2013074801A1 (en) 2011-11-18 2013-05-23 Stemtech International, Inc. Use of foti to enhance stem cell mobilization and proliferation
RU2015104535A (ru) * 2012-07-11 2016-08-27 Стемтек Интернэшнл, Инк. Композиции и способы для усиления мобилизации и пролиферации бластомероподобных стволовых клеток
CN104822827B (zh) 2012-12-06 2020-01-21 干细胞生物科技公司 Lgr5+体干细胞
EP2746769A1 (en) * 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
US20150141901A1 (en) * 2013-11-08 2015-05-21 Alan S. Lichtbroun Low-level laser irradiation of stimulated human stem cells
RS59437B2 (sr) 2013-12-03 2025-01-31 Gerolymatos Int S A Jonske vodene kompozicije
CN107312063A (zh) * 2017-06-22 2017-11-03 乐清瑞耀食品技术有限公司 钝顶螺旋藻活性蛋白的制备方法
FR3087338B1 (fr) 2018-10-22 2020-10-09 Amadeite Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
US12188049B2 (en) * 2020-04-14 2025-01-07 Tzu Chi University Methods for mobilizing stem cells

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002069443A (ja) * 2000-08-30 2002-03-08 Microalgae Corporation 抗酸化剤及び該抗酸化剤を含有する化粧料

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5663911A (en) 1979-10-29 1981-05-30 Dainippon Ink & Chem Inc Cosmetic containing hard-soluble phycocyanin
US6309639B1 (en) * 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
EP1681299B1 (en) * 2000-03-27 2009-11-11 Genetics Institute, LLC Methods for purifying highly anionic proteins
PL203814B1 (pl) 2000-07-10 2009-11-30 Univ Mississippi Preparat immunostymulujacy wyodrębniony z mikroalg, kompozycja farmaceutyczna i suplement diety zawierające ten preparat, zastosowanie preparatu immunostymulującego oraz sposób otrzymywania tego preparatu z jadalnych mikroalg
ES2338757T3 (es) * 2000-10-18 2010-05-12 The Brigham And Women's Hospital, Inc. Polipeptidos ligandos para selectina-e/selectina-l de la celula hematopoyetica y metodos de utilizacion de los mismos.
US6814961B1 (en) 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
FR2850277B1 (fr) * 2003-01-24 2005-04-08 Lanatech Composition comprenant un extrait d'aphanizomenon flos-aquae, son utilisation et sa preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002069443A (ja) * 2000-08-30 2002-03-08 Microalgae Corporation 抗酸化剤及び該抗酸化剤を含有する化粧料

Also Published As

Publication number Publication date
JP5006877B2 (ja) 2012-08-22
CA2612694A1 (en) 2007-01-04
EP1895973A1 (en) 2008-03-12
US20070003647A1 (en) 2007-01-04
RU2008100847A (ru) 2009-07-27
US20100209461A1 (en) 2010-08-19
US7651690B2 (en) 2010-01-26
EP1895973B1 (en) 2015-08-19
NZ565346A (en) 2010-05-28
IL188192A (en) 2014-04-30
IL188192A0 (en) 2011-08-01
BRPI0612672B8 (pt) 2021-05-25
US7947284B2 (en) 2011-05-24
HK1114024A1 (zh) 2008-10-24
KR20080030047A (ko) 2008-04-03
AU2006261852B2 (en) 2012-07-19
CA2612694C (en) 2015-10-27
US20100092507A1 (en) 2010-04-15
WO2007002570A1 (en) 2007-01-04
RU2417093C2 (ru) 2011-04-27
BRPI0612672B1 (pt) 2018-12-11
BRPI0612672A2 (pt) 2010-11-30
JP2008546808A (ja) 2008-12-25
ES2546332T3 (es) 2015-09-22
AU2006261852A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
US7947284B2 (en) Purified component of blue-green algae and method of use
US8414881B2 (en) Method for enhancing stem cell trafficking
US20190276803A1 (en) Method of culturing immune cells, kit for thereof, immune cell cultured medium obtained by same method, cosmetic composition and pharmaceutical composition comprising thereof
JP5872041B2 (ja) 幹細胞由来微小胞を含む神経生成促進用組成物
Korpelainen et al. The receptor for interleukin 3 is selectively induced in human endothelial cells by tumor necrosis factor alpha and potentiates interleukin 8 secretion and neutrophil transmigration.
KR20140011295A (ko) 줄기 세포 동원을 증진시키는 방법 및 조성물
JP2018023343A (ja) 細胞培養用培地、及び細胞培養方法
JP2015522076A (ja) 割球様幹細胞の動員および増殖を向上させるための組成物および方法
KR102601831B1 (ko) 고형암 증식 억제 효과를 갖는 개과동물의 엑소좀
Cesar et al. Activation of mononuclear bone marrow cells treated in vitro with a complex homeopathic medication
KR20210002205A (ko) 면역세포 배양액 함유 조성물의 제조방법 및 기능성 화장품 조성물
HK1114024B (en) Purified extracts of blue-green algae and method of use
JPWO2010008005A1 (ja) ストレスによって誘導される免疫機能変調改善剤
MX2007016597A (es) Componente purificado de algas azules-verdes y metodo de uso
JP3970916B2 (ja) ナチュラルキラー細胞の増殖剤及び増殖方法
US20150359827A1 (en) Blue-green algae extract mixtures and methods of use
Shichkin Stem cells of the thymus
KR20250175731A (ko) 이식편대숙주질환 치료용 조성물
KR101438896B1 (ko) 인간 혈액 유래 혈구 세포괴를 포함하는 면역관련 질환 치료용 약학적 조성물
Emmons The influence of exercise training on the bone marrow microenvironment in obesity and cancer

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20180103

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20190103

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20200103

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20230130

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20230130